Secondly, Lazarov et al [15] showed that exposure of transgenic mice to an enriched environment results in pronounced reductions in deposits of cerebral beta-amyloid peptides, a hallmark of Alzheimer's disease, compared to animals raised under standard housing conditions. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.